KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,901,000 | +29.5% | 2,372,234 | +17.3% | 0.00% | +50.0% |
| Q3 2016 | $10,735,000 | -14.0% | 2,021,682 | +7.3% | 0.00% | -33.3% |
| Q2 2016 | $12,478,000 | +7.7% | 1,884,848 | -24.1% | 0.00% | 0.0% |
| Q1 2016 | $11,590,000 | -10.7% | 2,481,833 | -3.4% | 0.00% | 0.0% |
| Q4 2015 | $12,976,000 | +49.8% | 2,569,538 | +4.4% | 0.00% | +50.0% |
| Q3 2015 | $8,660,000 | -65.1% | 2,460,288 | -1.0% | 0.00% | -66.7% |
| Q2 2015 | $24,796,000 | -25.4% | 2,484,529 | -4.8% | 0.01% | -25.0% |
| Q1 2015 | $33,221,000 | +0.6% | 2,609,640 | +11.8% | 0.01% | 0.0% |
| Q4 2014 | $33,025,000 | +20.8% | 2,333,888 | +17.4% | 0.01% | 0.0% |
| Q3 2014 | $27,329,000 | -13.2% | 1,987,560 | -2.9% | 0.01% | -11.1% |
| Q2 2014 | $31,489,000 | -26.1% | 2,047,374 | -18.2% | 0.01% | -30.8% |
| Q1 2014 | $42,630,000 | +48.2% | 2,501,741 | +12.6% | 0.01% | +44.4% |
| Q4 2013 | $28,766,000 | +23.5% | 2,221,305 | -3.8% | 0.01% | +12.5% |
| Q3 2013 | $23,295,000 | +53.0% | 2,308,736 | +13.3% | 0.01% | +33.3% |
| Q2 2013 | $15,226,000 | – | 2,038,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |